{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:09:04Z","timestamp":1791580144507,"version":"4.3.4"},"reference-count":56,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T00:00:00Z","timestamp":1669420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of University and Research","award":["PON 03PE000_78_1"],"award-info":[{"award-number":["PON 03PE000_78_1"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Hyperuricemia and liver steatosis are risk factors for cardiovascular diseases and mortality. The use of natural compounds could be a safe and effective alternative to drugs for the treatment of fatty liver and hyperuricemia. Polyphenolic fraction of Citrus Bergamia in association with the extract of Cynara Cardunculus, as nutraceutical, is able to reduce body weight, hepatic steatosis and markers of oxidative stress. Then, we performed a secondary analysis of a double-blind placebo-controlled trial to examine the effects of this nutraceutical on serum uric acid levels in adults with fatty liver. Materials and Methods: The study included 94 individuals with hepatic steatosis. For six weeks, the intervention group was given a nutraceutical (300 mg\/day) comprising a Bergamot polyphenol fraction and Cynara Cardunculus extract. The control group received a daily pill of placebo. Serum uric acid, lipids, glucose and anthropometric parameters were assessed at baseline and after 6 weeks. Results: We found a greater reduction in serum uric acid in the participants taking the nutraceutical rather than placebo (\u22120.1 \u00b1 0.7 mg\/dL vs. 0.3 \u00b1 0.7 mg\/dL, p = 0.004), and especially in those with moderate\/severe hepatic steatosis also after adjustment for confounding variables. In addition, we analysed the two groups according to tertiles of uric acid concentration. Among participants taking the nutraceutical, we found in those with the highest baseline serum uric acid (&gt;5.4 mg\/dL) the greater reduction compared to the lowest baseline uric acid (\u22127.8% vs. +4.9%; adjusted p = 0.04). The stepwise multivariable analysis confirmed the association between the absolute serum uric acid change and nutraceutical treatment (B = \u22120.43; p = 0.004). Conclusions: A nutraceutical containing bioactive components from bergamot and wild cardoon reduced serum uric acid during 6 weeks in adults with fatty liver. Future investigations are needed to evaluate the efficacy of this nutraceutical in the treatment of hyperuricaemia.<\/jats:p>","DOI":"10.3390\/medicina58121728","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T03:28:49Z","timestamp":1669606129000},"page":"1728","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Citrus Bergamia and Cynara Cardunculus Reduce Serum Uric Acid in Individuals with Non-Alcoholic Fatty Liver Disease"],"prefix":"10.3390","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7503-6188","authenticated-orcid":false,"given":"Yvelise","family":"Ferro","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Science, University Magna Grecia, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7644-1337","authenticated-orcid":false,"given":"Samantha","family":"Maurotti","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University Magna Grecia, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3198-7090","authenticated-orcid":false,"given":"Elisa","family":"Mazza","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Science, University Magna Grecia, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Pujia","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Science, University Magna Grecia, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sciacqua","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Science, University Magna Grecia, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Musolino","sequence":"additional","affiliation":[{"name":"IRC-FSH-Pharmaceutical Biology-Department of Health Sciences, University Magna Grecia, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Mollace","sequence":"additional","affiliation":[{"name":"Department of Health Science, University Magna Grecia, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Pujia","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Science, University Magna Grecia, 88100 Catanzaro, Italy"},{"name":"Research Center for the Prevention and Treatment of Metabolic Diseases, University Magna Grecia, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7048-5830","authenticated-orcid":false,"given":"Tiziana","family":"Montalcini","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University Magna Grecia, 88100 Catanzaro, Italy"},{"name":"Research Center for the Prevention and Treatment of Metabolic Diseases, University Magna Grecia, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1758-5996-4-12","article-title":"High plasma uric acid concentration: Causes and consequences","volume":"4","author":"Burini","year":"2012","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","article-title":"Regulation of uric acid metabolism and excretion","volume":"213","author":"Maiuolo","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: Prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11926-012-0307-x","article-title":"Racial and gender disparities among patients with gout","volume":"15","author":"Singh","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12944-018-0712-x","article-title":"Gender-specific association of serum uric acid levels and cardio-ankle vascular index in Chinese adults","volume":"17","author":"Zheng","year":"2018","journal-title":"Lipids Health Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e26946","DOI":"10.1097\/MD.0000000000026946","article-title":"Relationship between serum uric acid level and nonalcoholic fatty liver disease in type 2 diabetes patients","volume":"100","author":"Yu","year":"2021","journal-title":"Medicine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"10072","DOI":"10.1038\/s41598-020-66931-9","article-title":"Association between serum uric acid and nonalcoholic fatty liver disease in nonobese postmenopausal women: A cross-sectional study","volume":"10","author":"Bao","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12944-017-0531-5","article-title":"Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults","volume":"16","author":"Zheng","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fendo.2020.00179","article-title":"Higher serum uric acid level predicts non-alcoholic fatty liver disease: A 4-year prospective cohort study","volume":"11","author":"Wei","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.atherosclerosis.2020.08.006","article-title":"Hyperuricemia precedes non-alcoholic fatty liver disease with abdominal obesity moderating this unidirectional relationship: Three longitudinal analyses","volume":"311","author":"Ma","year":"2020","journal-title":"Atherosclerosis"},{"key":"ref_11","first-page":"264","article-title":"Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"111","author":"Aller","year":"2019","journal-title":"Rev. Esp. Enferm. Dig. Organo Of. Soc. Esp. Patol. Dig."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/MEG.0000000000000931","article-title":"Hyperuricemia is associated with nonalcoholic fatty liver disease activity score in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"29","author":"Jaruvongvanich","year":"2017","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jhep.2016.12.025","article-title":"Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents","volume":"66","author":"Mosca","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jjcc.2020.12.013","article-title":"Uric acid and cardiovascular disease: A clinical review","volume":"78","author":"Saito","year":"2021","journal-title":"J. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ccl.2021.04.009","article-title":"The Impact of Uric Acid and Hyperuricemia on Cardiovascular and Renal Systems","volume":"39","author":"Agnoletti","year":"2021","journal-title":"Cardiol. Clin."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.amjcard.2021.05.007","article-title":"Relation of Serum Uric Acid and Cardiovascular Events in Young Adults Aged 20\u201349 Years","volume":"152","author":"Seki","year":"2021","journal-title":"Am. J. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/HYPERTENSIONAHA.119.13643","article-title":"Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years","volume":"75","author":"Virdis","year":"2020","journal-title":"Hypertension"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijcard.2015.08.087","article-title":"The treatment of hyperuricemia","volume":"213","author":"Gliozzi","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/14740338.2019.1594771","article-title":"Safety and tolerability of available urate-lowering drugs: A critical review","volume":"18","author":"Strilchuk","year":"2019","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jfma.2018.06.006","article-title":"Examining the use of allopurinol: Perspectives from recent drug injury relief applications","volume":"118","author":"Huang","year":"2019","journal-title":"J. Formos. Med. Assoc. Taiwan Yi Zhi"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.3748\/wjg.v23.i23.4146","article-title":"Antioxidant dietary approach in treatment of fatty liver: New insights and updates","volume":"23","author":"Ferramosca","year":"2017","journal-title":"World J Gastroenterol"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Roumeliotis, S., Roumeliotis, A., Dounousi, E., Eleftheriadis, T., and Liakopoulos, V. (2019). Dietary Antioxidant Supplements and Uric Acid in Chronic Kidney Disease: A Review. Nutrients, 11.","DOI":"10.3390\/nu11081911"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Jiang, L.L., Gong, X., Ji, M.Y., Wang, C.C., Wang, J.H., and Li, M.H. (2020). Bioactive Compounds from Plant-Based Functional Foods: A Promising Choice for the Prevention and Management of Hyperuricemia. Foods, 9.","DOI":"10.3390\/foods9080973"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41538-020-0063-7","article-title":"Inhibitory effect of Citrus flavonoids on the in vitro transport activity of human urate transporter 1 (URAT1\/SLC22A12), a renal re-absorber of urate","volume":"4","author":"Toyoda","year":"2020","journal-title":"NPJ Sci. Food"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1002\/jsfa.8774","article-title":"Consumption of orange fermented beverage improves antioxidant status and reduces peroxidation lipid and inflammatory markers in healthy humans","volume":"98","author":"Ortega","year":"2018","journal-title":"J. Sci. Food Agric."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3164\/jcbn.09-15","article-title":"Orange juice and hesperetin supplementation to hyperuricemic rats alter oxidative stress markers and xanthine oxidoreductase activity","volume":"45","author":"Haidari","year":"2009","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6000","DOI":"10.1039\/C9FO00509A","article-title":"Effect of lemon water soluble extract on hyperuricemia in a mouse model","volume":"10","author":"Chen","year":"2019","journal-title":"Food Funct."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S430","DOI":"10.4103\/pm.pm_14_17","article-title":"Biological Effect of Cynara cardunculus on Kidney Status of Hypercholesterolemic Rats","volume":"13","author":"Alkushi","year":"2017","journal-title":"Pharmacogn. Mag."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s12967-022-03579-1","article-title":"A new nutraceutical (Livogen Plus\u00ae) improves liver steatosis in adults with non-alcoholic fatty liver disease","volume":"20","author":"Ferro","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Mirarchi, A., Mare, R., Musolino, V., Nucera, S., Mollace, V., Pujia, A., Montalcini, T., Romeo, S., and Maurotti, S. (2022). Bergamot Polyphenol Extract Reduces Hepatocyte Neutral Fat by Increasing Beta-Oxidation. Nutrients, 14.","DOI":"10.3390\/nu14163434"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Parafati, M., Lascala, A., La Russa, D., Mignogna, C., Trimboli, F., Morittu, V.M., Riillo, C., Macirella, R., Mollace, V., and Brunelli, E. (2018). Bergamot Polyphenols Boost Therapeutic Effects of the Diet on Non-Alcoholic Steatohepatitis (NASH) Induced by \u201cJunk Food\u201d: Evidence for Anti-Inflammatory Activity. Nutrients, 10.","DOI":"10.3390\/nu10111604"},{"key":"ref_32","first-page":"931","article-title":"Therapeutic Potential of Artichoke in the Treatment of Fatty Liver: A Systematic Review and Meta-Analysis","volume":"25","author":"Kamel","year":"2022","journal-title":"J. Med. Food"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3389\/fendo.2020.00494","article-title":"Randomized clinical trial: Bergamot citrus and wild cardoon reduce liver steatosis and body weight in non-diabetic individuals aged over 50 years","volume":"11","author":"Ferro","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jtcme.2020.02.004","article-title":"The synergistic effect of Citrus bergamia and Cynara cardunculus extracts on vascular inflammation and oxidative stress in non-alcoholic fatty liver disease","volume":"10","author":"Musolino","year":"2020","journal-title":"J. Tradit. Complement. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3350\/cmh.2017.0019","article-title":"Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals","volume":"23","author":"Ferro","year":"2017","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12967-020-02676-3","article-title":"Effect of a novel functional tomato sauce (OsteoCol) from vine-ripened tomatoes on serum lipids in individuals with common hypercholesterolemia: Tomato sauce and hypercholesterolemia","volume":"19","author":"Ferro","year":"2021","journal-title":"J. Transl. Med."},{"key":"ref_37","first-page":"679","article-title":"Drug-induced hyperuricaemia and gout","volume":"56","author":"Slim","year":"2017","journal-title":"Rheumatology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4172\/jbb.1000173","article-title":"Effects on uric acid metabolism of the drugs except the antihyperuricemics","volume":"6","author":"Moriwaki","year":"2014","journal-title":"J. Bioequivalence Bioavailab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1172\/JCI43132","article-title":"Caught red-handed: Uric acid is an agent of inflammation","volume":"120","author":"Shi","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1161\/ATVBAHA.117.309128","article-title":"Uric Acid Is Associated with Inflammatory Biomarkers and Induces Inflammation Via Activating the NF-\u03baB Signaling Pathway in HepG2 Cells","volume":"37","author":"Spiga","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/annrheumdis-2015-eular.5147","article-title":"SAT0318 Lemon Juice Reduces Serum Uric Acid Level Via Alkalization of Urine in Gouty and Hyperuremic Patients\u2014A Pilot Study","volume":"74","author":"Biernatkaluza","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.scienta.2017.03.023","article-title":"Lemon fruits lower the blood uric acid levels in humans and mice","volume":"220","author":"Wang","year":"2017","journal-title":"Sci. Hortic."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Liu, K., Wang, W., Guo, B.H., Gao, H., Liu, Y., Liu, X.H., Yao, H.L., and Cheng, K. (2016). Chemical Evidence for Potent Xanthine Oxidase Inhibitory Activity of Ethyl Acetate Extract of Citrus aurantium L. Dried Immature Fruits. Molecules., 21.","DOI":"10.3390\/molecules21030302"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1248\/bpb.30.1551","article-title":"Hypouricemic action of selected flavonoids in mice: Structure\u2013activity relationships","volume":"30","author":"Mo","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-2008-1034316","article-title":"Flavonoids of Cynara scolymus possess potent xanthinoxidase inhibitory activity in vitro but are devoid of hypouricemic effects in rats after oral application","volume":"74","author":"Sarawek","year":"2008","journal-title":"Planta Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1142\/S0192415X1450092X","article-title":"Study on the anti-gout activity of chlorogenic acid: Improvement on hyperuricemia and gouty inflammation","volume":"42","author":"Meng","year":"2014","journal-title":"Am. J. Chin. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3390\/nu2070737","article-title":"Dietary polyphenols and obesity","volume":"2","author":"Meydani","year":"2010","journal-title":"Nutrients"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"(2016). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol., 64, 1388\u20131402.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","article-title":"Controlled attenuation parameter (CAP): A novel VCTE\u2122 guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: Preliminary study and validation in a cohort of patients with chronic liver disease from various causes","volume":"36","author":"Sasso","year":"2010","journal-title":"Ultrasound Med. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12020-022-03157-x","article-title":"Ultrasound and FibroScan\u00ae Controlled Attenuation Parameter in patients with MAFLD: Head to head comparison in assessing liver steatosis","volume":"78","author":"Salmi","year":"2022","journal-title":"Endocrine"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"(2021). EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis\u20142021 update. J. Hepatol., 75, 659\u2013689.","DOI":"10.1016\/j.jhep.2021.05.025"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e12393","DOI":"10.1111\/cob.12393","article-title":"Bariatric surgery during the evolution of fatty liver-A randomized clinical trial comparing gastric bypass and sleeve gastrectomy based on transient elastography","volume":"10","author":"Fonseca","year":"2020","journal-title":"Clin. Obes."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"610","DOI":"10.21037\/hbsn-20-787","article-title":"Accuracy of non-invasive liver stiffness measurement and steatosis quantification in patients with severe and morbid obesity","volume":"10","author":"Eilenberg","year":"2021","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s10067-017-3613-x","article-title":"DASH diet and change in serum uric acid over time","volume":"36","author":"Tang","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"ref_55","first-page":"4186","article-title":"Potency on lowering serum uric acid in gout patients: A pooled analysis of registrative studies comparing febuxostat vs. allopurinol","volume":"21","author":"Cutolo","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13075-021-02461-7","article-title":"Incident gout and weight change patterns: A retrospective cohort study of US adults","volume":"23","author":"Bai","year":"2021","journal-title":"Arthritis Res. Ther."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/12\/1728\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:27:26Z","timestamp":1760146046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/12\/1728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,26]]},"references-count":56,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["medicina58121728"],"URL":"https:\/\/doi.org\/10.3390\/medicina58121728","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,26]]}}}